The conservation of biodiversity is a matter of economic necessity, as biological resources are not externalities but direct inputs to major global industries. The “productive use value” of these resources—their commercial value in formal markets—is a critical component of the global economy, making its degradation a direct threat to economic stability and growth.

A key takeaway from global analysis underscores this dependency:

At least 40 percent of the world’s economy and 80 percent of the needs of the poor are derived from biological resources.

“Productive Use Value” is specifically defined as “the commercial value of products that are commercially harvested for exchange in formal markets.” An analysis of key industrial sectors reveals the depth of this reliance.

Agriculture The foundation of modern agriculture lies in biodiversity. The crops cultivated today originated from wild varieties, and biotechnologists continue to rely on the gene pool from these wild species to develop new, high-yielding, and disease-resistant strains. Wild relatives of crop plants provide the genetic material essential for agricultural innovation and food security.

Animal Husbandry All domesticated animals, which are central to the global food supply, derive from wild ancestral species. The modern fields of poultry farming, dairy farming, and pisciculture depend on scientific breeding techniques that improve traits and yields of milk, meat, and other animal products, a process that began with the genetic diversity found in nature.

Energy Sector The dominant energy sources of the modern era—fossil fuels like coal, petroleum, and natural gas—are direct products of past biodiversity. These resources are essentially “gifts of biodiversity from the geological past,” formed from the decay of organic matter over millions of years.

Pharmaceuticals and Medicine The healthcare sector is profoundly dependent on biodiversity. A majority of modern pharmaceutical drugs are not synthesized from scratch but are extracted from various plants. The world’s ecosystems are a vast repository of chemical compounds with potential medical applications, many of which remain undiscovered.

Industrial Innovation and Biotechnology Biodiversity provides a “rich storehouse” of materials and inspiration for industrialists to develop new products. The process of searching for and developing new crop varieties from the genetic material found in their wild relatives is a key biotechnological practice known as “biological prospecting.” This process highlights the immense, often untapped, potential for future economic development locked within natural ecosystems.

The immense productive value of biodiversity across these sectors establishes it as a core economic asset, and its ongoing degradation poses a significant risk to future prosperity.